BLRX
BioLineRX
BLRX
BLRX
14 hedge funds and large institutions have $104K invested in BioLineRX in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
97% less call options, than puts
Call options by funds: $2K | Put options by funds: $77K
Holders
14
Holding in Top 10
–
Calls
$2K
Puts
$77K
Top Buyers
| 1 | +$24.1K | |
| 2 | +$16.7K | |
| 3 | +$147 | |
| 4 |
Rockefeller Capital Management
New York
|
+$45 |
Top Sellers
| 1 | -$63.1K | |
| 2 | -$50.7K | |
| 3 | -$18.7K | |
| 4 |
Citigroup
New York
|
-$18.3K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$4.55K |
